-
In this study of patients presenting with ST-elevation myocardial infarction and multivessel disease, nonculprit vessel percutaneous coronary intervention (PCI) guided by fractional flow reserve failed to show benefit vs. angiography-guided PCI in terms of clinical events at one year.
-
A recent study of patients who had undergone a percutaneous coronary intervention and were transitioning from dual antiplatelet therapy to monotherapy showed clopidogrel was superior to aspirin for preventing further major adverse events, including bleeding.
-
Among patients with newly diagnosed atrial fibrillation age 66-74 years without other CHA2DS2-VASc risk factors for thromboembolism, the older they are in this age range, the more likely they are to experience a stroke.
-
By adding dapagliflozin to maximally tolerated standard therapy for heart failure with reduced left ventricular ejection fraction, researchers noted the reduction in mortality and recurrent heart failure began within one month of starting this therapy.
-
Management of tracheostomy emergencies requires the use of specialized knowledge, resources, and equipment. Specific complications that the emergency physician should be familiar with are discussed.
-
Substance abuse is a major healthcare issue with effects on all aspects of patient care, including trauma. A large percentage of trauma patients have a positive drug screen, and acute and chronic abuse have impacts both on the acute and long-term management of these patients. This report is the first of a two-part series and focuses on stimulants and substances with sympathomimetic properties, with particular attention to the impact on the trauma patient.
-
With many COVID-19 deaths unreported in the United States, researchers estimate the actual death toll of the pandemic is closer to 1 million than the 574,043 reported from March 1, 2020, to May 3, 2021. Looking at excess mortality data, researchers at the University of Washington’s Institute for Health Metrics and Evaluation calculated 905,289 COVID-19 deaths occurred in the U.S. during that period. That is 58% higher than the official numbers.
-
Emergency physicians who find themselves defendants do have resources — at their hospitals, from their professional liability carriers, from mental health professionals, and from specialty organizations.
-
During litigation, two important questions will arise: How did the hospital keep the patient safe? Was the hospital not doing reasonable things that other hospitals were doing?
-
Due to “needle safety device failures” — some of which led to needlesticks — the FDA is recommending healthcare providers stop using certain syringes and needles manufactured by Guangdong Haiou Medical Apparatus Co., Ltd. (HAIOU). The FDA is recommending the action as it evaluates the products. So far, HAIOU has not initiated a voluntary recall.
